Cleared Traditional

K181893 - T-PLUS (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K181893 · Wintecare SA · General & Plastic Surgery device
Jan 2019
Decision
200d
Days
Class 2
Risk

K181893 is an FDA 510(k) clearance for the T-PLUS. Classified as Massager, Vacuum, Radio Frequency Induced Heat (product code PBX), Class II - Special Controls.

Submitted by Wintecare SA (Chiasso, CH). The FDA issued a Cleared decision on January 29, 2019 after a review of 200 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

Submission Details

510(k) Number K181893 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2018
Decision Date January 29, 2019
Days to Decision 200 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Regulatory Context
Review time vs. panel average
68d slower than avg
Panel avg: 132d · This submission: 200d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PBX Massager, Vacuum, Radio Frequency Induced Heat
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Generates Heat In Body Tissues For Minor Relief Of Minor Aches And Pain. Mechanical Massaging To Provide A Temporary Reduction In The Appearance Of Cellulite.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - PBX Massager, Vacuum, Radio Frequency Induced Heat

All 8
Devices cleared under the same product code (PBX) and FDA review panel - the closest regulatory comparables to K181893.
Apollo Quattro (APQ-10M)
K253261 · Weero Co., Ltd. · Mar 2026
NeoSculpt Plus
K252888 · S&M Medical Co., Ltd. · Mar 2026
OptiLUV Device
K250734 · Pollogen, Ltd. · Sep 2025
WinForth (LM-E470KA)
K250916 · Shenzhen Leaflife Technology Co., Ltd. · Aug 2025
Zionic Pro Max (Radiofrequency)
K243716 · Termosalud S.L. · May 2025
HEBE (NP0000763)
K241733 · Novasonix Technology S.L. · Apr 2025